160 related articles for article (PubMed ID: 32788260)
1. Pregnancy in lymphangioleiomyomatosis: clinical and lung function outcomes in two national cohorts.
Taveira-DaSilva AM; Johnson SR; Julien-Williams P; Johnson J; Stylianou M; Moss J
Thorax; 2020 Oct; 75(10):904-907. PubMed ID: 32788260
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy experiences among women with lymphangioleiomyomatosis.
Cohen MM; Freyer AM; Johnson SR
Respir Med; 2009 May; 103(5):766-72. PubMed ID: 19117742
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary lymphangioleiomyomatosis. A study of 69 patients. Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P).
Urban T; Lazor R; Lacronique J; Murris M; Labrune S; Valeyre D; Cordier JF
Medicine (Baltimore); 1999 Sep; 78(5):321-37. PubMed ID: 10499073
[TBL] [Abstract][Full Text] [Related]
4. Reductions in pulmonary function detected in patients with lymphangioleiomyomatosis: An analysis of the Japanese National Research Project on Intractable Diseases database.
Hayashida M; Yasuo M; Hanaoka M; Seyama K; Inoue Y; Tatsumi K; Mishima M;
Respir Investig; 2016 May; 54(3):193-200. PubMed ID: 27108015
[TBL] [Abstract][Full Text] [Related]
5. Low initial KCO predicts rapid FEV1 decline in pulmonary lymphangioleiomyomatosis.
Lazor R; Valeyre D; Lacronique J; Wallaert B; Urban T; Cordier JF;
Respir Med; 2004 Jun; 98(6):536-41. PubMed ID: 15191039
[TBL] [Abstract][Full Text] [Related]
6. Successful pregnancy complicated by persistent pneumothorax in a patient with lymphangioleiomyomatosis (LAM) on sirolimus.
Faehling M; Frohnmayer S; Leschke M; Trinajstic-Schulz B; Weber J; Liewald F
Sarcoidosis Vasc Diffuse Lung Dis; 2011 Oct; 28(2):153-5. PubMed ID: 22117507
[TBL] [Abstract][Full Text] [Related]
7. Lymphangioleiomyomatosis and pregnancy: a mini-review.
Zhou J; Diao M
Arch Gynecol Obstet; 2024 Jun; 309(6):2339-2346. PubMed ID: 38594407
[TBL] [Abstract][Full Text] [Related]
8. COPD assessment test as a possible tool for evaluating health-related quality of life in lymphangioleiomyomatosis.
Kato M; Kanehiro Y; Yoshimi K; Kodama Y; Sekiya M; Sato T; Takahashi K; Seyama K;
Respir Investig; 2018 Nov; 56(6):480-488. PubMed ID: 30143460
[TBL] [Abstract][Full Text] [Related]
9. Ultra-Small Lung Cysts Impair Diffusion Without Obstructing Air Flow in Lymphangioleiomyomatosis.
Matthew BP; Hasani AM; Chen YC; Pirooznia M; Stylianou M; Rollison SF; Machado TR; Quade NM; Jones AM; Julien-Williams P; Taveira-DaSilva A; Chen MY; Moss J; Wen H
Chest; 2021 Jul; 160(1):199-208. PubMed ID: 33549601
[TBL] [Abstract][Full Text] [Related]
10. Quantitative CT predicts the severity of physiologic dysfunction in patients with lymphangioleiomyomatosis.
Crausman RS; Lynch DA; Mortenson RL; King TE; Irvin CG; Hale VA; Newell JD
Chest; 1996 Jan; 109(1):131-7. PubMed ID: 8549175
[TBL] [Abstract][Full Text] [Related]
11. Emerging clinical picture of lymphangioleiomyomatosis.
Cohen MM; Pollock-BarZiv S; Johnson SR
Thorax; 2005 Oct; 60(10):875-9. PubMed ID: 16055626
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the MILES cohort reveals determinants of disease progression and treatment response in lymphangioleiomyomatosis.
Gupta N; Lee HS; Young LR; Strange C; Moss J; Singer LG; Nakata K; Barker AF; Chapman JT; Brantly ML; Stocks JM; Brown KK; Lynch JP; Goldberg HJ; Downey GP; Taveira-DaSilva AM; Krischer JP; Setchell K; Trapnell BC; Inoue Y; McCormack FX;
Eur Respir J; 2019 Apr; 53(4):. PubMed ID: 30846465
[TBL] [Abstract][Full Text] [Related]
13. Is sirolimus a therapeutic option for patients with progressive pulmonary lymphangioleiomyomatosis?
Neurohr C; Hoffmann AL; Huppmann P; Herrera VA; Ihle F; Leuschner S; von Wulffen W; Meis T; Baezner C; Leuchte H; Baumgartner R; Zimmermann G; Behr J
Respir Res; 2011 May; 12(1):66. PubMed ID: 21600034
[TBL] [Abstract][Full Text] [Related]
14. Clinical experience of lymphangioleiomyomatosis in the UK.
Johnson SR; Tattersfield AE
Thorax; 2000 Dec; 55(12):1052-7. PubMed ID: 11083892
[TBL] [Abstract][Full Text] [Related]
15. Retrospective review of combined sirolimus and simvastatin therapy in lymphangioleiomyomatosis.
Taveira-DaSilva AM; Jones AM; Julien-Williams PA; Stylianou M; Moss J
Chest; 2015 Jan; 147(1):180-187. PubMed ID: 25167325
[TBL] [Abstract][Full Text] [Related]
16. Lymphangioleiomyomatosis.
Doubková M; Štefániková M; Čan V; Merta Z; Svoboda M
Klin Onkol; 2019; 32(5):367-374. PubMed ID: 31610670
[TBL] [Abstract][Full Text] [Related]
17. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis.
Bissler JJ; McCormack FX; Young LR; Elwing JM; Chuck G; Leonard JM; Schmithorst VJ; Laor T; Brody AS; Bean J; Salisbury S; Franz DN
N Engl J Med; 2008 Jan; 358(2):140-51. PubMed ID: 18184959
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of low-dose Sirolimus in Lymphangioleiomyomatosis.
Yoon HY; Hwang JJ; Kim DS; Song JW
Orphanet J Rare Dis; 2018 Nov; 13(1):204. PubMed ID: 30428897
[TBL] [Abstract][Full Text] [Related]
19. Lymphangioleiomyomatosis.
Taveira-DaSilva AM; Steagall WK; Moss J
Cancer Control; 2006 Oct; 13(4):276-85. PubMed ID: 17075565
[TBL] [Abstract][Full Text] [Related]
20. Severity and outcome of cystic lung disease in women with tuberous sclerosis complex.
Taveira-DaSilva AM; Jones AM; Julien-Williams P; Yao J; Stylianou M; Moss J
Eur Respir J; 2015 Jan; 45(1):171-80. PubMed ID: 25537563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
